Jiang, Rong
Ai, Zi-Sheng
Jiang, Xin
Yuan, Ping
Liu, Dong
Zhao, Qin-Hua
He, Jing
Wang, Lan
Gomberg-Maitland, Mardi
Jing, Zhi-Cheng
Article History
Received: 11 October 2014
Revised: 7 November 2014
Accepted: 24 November 2014
First Online: 19 March 2015
Competing interests
: Dr Z-C Jing serves as a consultant and scientific advisor to Actelion, Bayer Schering, AstraZeneca, Pfizer and United Therapeutics, in addition to being an investigator in trials sponsored by these companies. Actelion, Gilead, Medtronic, Novartis, Lung Biotechnology, Reata, and Ventripoint have provided funding to the University of Chicago to support Dr Gomberg-Maitland’s conduct of clinical trials. Dr Gomberg-Maitland has served as a consultant for Actelion, Bayer, Gilead, Medtronic, Bellerophon (formerly known as Ikaria) and United Therapeutics, as a member of steering committees and DSMB/event committees. She has received honoraria for CME from Medscape and ABComm. Dr Gomberg-Maitland is a member of the PCORI Advisory Panel on Rare Diseases and a Special Government Employee in the FDA’s Cardio-Renal Division. The other authos declare no conflict of interest.